BNTX (BioNTech SE) Forward P/E Multiple
Institutional confidence in BioNTech SE (BNTX) oncology remains steady, as evidenced by the company's forward P/E NTM. Current price action via the 0.00 indicator demonstrates a price consolidation phase. While its status as a scientific pioneer in mRNA therapy strengthens the brand image, declining revenues from COVID-19 products and the risks of clinical failures are exerting significant pressure on the asset's quotes.
Analytical breakdowns for BioNTech SE
- current price and projected stock value:
- business market valuation indicators:
- book capitalization information:
- debt and liquidity details:
- company profitability and valuation multiples indicators:
BNTX - Net Financial Result|Expected Profit BioNTech SE|BNTX - Market Cap to Earnings|Future Price to Earnings BioNTech Group|BNTX - Growth-Adjusted P/E Ratio|Enterprise Value to EBITDA Ratio BioNTech Inc.|BNTX - Company profit before taxes, interest and amortization|Net earnings per share (EPS TTM) BioNTech|BNTX - Net earnings per one share for the last twelve months|Quarterly EPS earnings growth biontech.de|BNTX - Net earnings per share growth this year|Earnings growth forecast for next year BioNTech SE
Summary company analytics:BioNTech
When constructing a long-term portfolio, the priority screening stage is the analysis of expected earnings. The forward P/E measures the current share price relative to the projected EPS, reflecting market expectations for future growth. The consistent recruitment of global oncologists and mRNA researchers confirms the scaling potential of BioNTech SE (BNTX). The value of 0.00 indicates the current equity premium. The price action regarding the company's valuation based on the forward P/E determines the sustainability of this trend.
Competitors of BioNTech SE (BNTX)
Projected Price to Earnings ARGX (argenx)|ABVX (ABIVAX) - Future Price to Earnings Multiple|Forward P/E Multiple ADMA (ADMA Bio)|Market Cap to Projected Earnings Protagonist Corp (PTGX)|IMVT - Future Price to Earnings|kiniksa.com (KNSA) - Projected Price to Earnings|Grifols (GRFS) - Future Price to Earnings|Projected Price to Earnings Adaptive Biotech|Projected Price to Earnings CLDX|Forward P/E Multiple Aurinia Corp|Future Price to Earnings BioCryst (BCRX)|veratx.com - Price to Future Earnings Ratio|Forward P/E Multiple DNTH (Dianthus Therapeutics, Inc.)|Pharvaris NV (PHVS) - Projected Price to Earnings Ratio|AbCellera Bio - Forward P/E Multiple|TRML: Future Price to Earnings|PGEN: Forward P/E Multiple|PHAR - Market Cap to Projected Earnings|Future Price to Earnings Nektar Therapeutics Inc.|Projected Price to Earnings Ratio Upstream Bio, Inc. UPB|Future Price to Earnings Zenas Biopharma, Inc. (ZBIO)|Immunome Bio - Price to Future Earnings Ratio|Gossamer Bio, Inc. - Projected Price to Earnings|Market Cap to Future Earnings Ratio KALV (kalvista.com)|Septerna - Forward P/E Multiple|Projected Price to Earnings Ratio Pieris Pharma|SVRA: Forward P/E Multiple|Projected Price to Earnings Rigel Corp|ANAB (AnaptysBio, Inc.) - Forward P/E Multiple|ATXS: Future Price to Earnings Multiple|Projected Price to Earnings ENGN (enGene)|RAPT (RAPT Therapeutics Inc.) - Future Price to Earnings Multiple|Future Price to Earnings Aerovate Therapeutics JBIO|Market Cap to Projected Earnings Aclaris Therapeutics, Inc (ACRS)|Kyverna Therapeutics - Forward P/E Multiple|Projected Price to Earnings Ratio tizianalifesciences.com|CABA: Forward P/E Multiple|VTYX (Ventyx Biosciences Inc.) - Future Price to Earnings|Future Price to Earnings Theratechnologies Inc|Price to Future Earnings Ratio AVTX (Avalo Therapeutics Inc)|Projected Price to Earnings ELDN (Eledon Pharmaceuticals)|Market Cap to Future Earnings Ratio AGEN|Climb Bio - Projected Price to Earnings|ZURA: Price to Future Earnings Ratio|ATYR - Future Price to Earnings|Price to Expected Earnings Ratio ADAG|IMA: Forward P/E Multiple|Shattuck Labs - Future Price to Earnings Multiple|EQ (Equillium Inc) - Forward P/E Multiple|Forward P/E Multiple Connect Pharma|Future Price to Earnings Immunic, Inc. (IMUX)|ATRA (atarabio.com) - Future Price to Earnings Multiple|Future Price to Earnings InflaRx IFRX|XFOR - Projected Price to Earnings|Adicet - Forward P/E Multiple|CELU - Forward P/E Multiple|INMB (INmune Bio Corp) - Projected Price to Earnings|Barinthus Biotherapeutics Corp - Future Price to Earnings Multiple|KZR (Kezar Life Sciences) - Forward P/E Multiple|sabbiotherapeutics.com (SABS) - Market Cap to Projected Earnings|Future Price to Earnings Akari Therapeutics Plc (AKTX)|Projected Price to Earnings enlivex.com ENLV|Future Price to Earnings Q32 Bio QTTB|GOVX - Projected Price to Earnings|EDSA: Projected Price to Earnings|IBIO - Forward P/E Multiple|carismatx.com (CARM) - Future Price to Earnings|Price to Future Earnings Ratio XTLB|BOLT (Bolt Biotherapeutics Inc.) - Forward P/E Multiple|Projected Price to Earnings Ratio HCW Biologics Inc HCWB|Forward P/E Multiple APVO|Future Price to Earnings AIM (AIM ImmunoTech, Inc.)|Forward P/E Multiple ADTX (Aditxt, Inc.)|Market Cap to Projected Earnings GRI Bio Inc (GRI)|XRTX - Future Price to Earnings|Projected Price to Earnings Ratio Vyome Therapeutics|Revelation Biosciences (REVB) - Future Price to Earnings|Price to Future Earnings Ratio INDP|Projected Price to Earnings SCNI|CALI (CalciMedica Corp) - Market Cap to Future Earnings Ratio|Forward P/E Multiple AFMD|ALLK - Projected Price to Earnings Ratio|Forward P/E Multiple HOOK (HOOKIPA Pharma)|IGMS - Projected Price to Earnings|iTeos Therapeutics, Inc. - Forward P/E Multiple|Future Price to Earnings Multiple OCEA (Ocean Biomedical Inc)|TCBP (TC BioPharm (Holdings) PLC) - Projected Price to Earnings|Third Harmonic Bio Inc - Future Price to Earnings Multiple
